Default company panoramic image
1cda275e d870 48e1 9305 481a9fe6ce6d

University of Colorado School of Medicine

We are developing a method for peptide sequencing that will increase throughput and sensitivity of protein detection by orders of magnitude.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Aurora, CO, USA
  • Currency USD
  • Employees 2

Company Summary


  • Default avatar
    Mantas Prekeris

    Monty is the lead engineer for the development of microfluidic platforms for data analysis and software development.

  • Default avatar
    Kerri York

    Kerri is the technical lead for developing and optimizing peptide derivatization and cleavage schemes.

  • Default avatar
    Jay Hesselberth

    I am the originator of the concepts underlying next-generation peptide sequencing and am intimately involved in the design and implementation of the technology.


  • Default avatar
    Patent filed with Swanson & Bratschun LLC

Previous Investors

  • Default avatar
    Damon Runyon Cancer Research Foundation / Andy Rachleff